Shenzhen Salubris Pharmaceuticals Co Ltd. said its Hong Kong Unit plans to boost Salubris Biotherapeutics Inc.'s capital by $35 million. The Company said it plans to spin off medical instrument unit for listing in Shanghai Star Market.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.54 CNY | +1.19% | -1.19% | -3.43% |
23/04 | Salubris Pharmaceuticals' Q1 Profit Falls 5% Despite 23% Rise in Operating Income | MT |
23/04 | Salubris Pharmaceuticals to Raise Capital of US Unit by $35 Million | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.43% | 4.71B | |
+18.67% | 43.74B | |
+23.52% | 22.26B | |
+16.41% | 14.9B | |
+9.03% | 13.39B | |
+40.48% | 12.12B | |
-9.68% | 6.92B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.47B |
- Stock Market
- Equities
- 002294 Stock
- News Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Salubris Pharmaceuticals Plans to Spin Off Medical Instrument Unit for Listing